JP2020519593A - 溶解度を増強させた薬物含有製剤 - Google Patents

溶解度を増強させた薬物含有製剤 Download PDF

Info

Publication number
JP2020519593A
JP2020519593A JP2019561320A JP2019561320A JP2020519593A JP 2020519593 A JP2020519593 A JP 2020519593A JP 2019561320 A JP2019561320 A JP 2019561320A JP 2019561320 A JP2019561320 A JP 2019561320A JP 2020519593 A JP2020519593 A JP 2020519593A
Authority
JP
Japan
Prior art keywords
acid
composition
drug
combination
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019561320A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020519593A5 (https=
Inventor
マイケル レアード ハレー
マイケル レアード ハレー
ドラゼン オストヴィック
ドラゼン オストヴィック
ピーター ノイマー
ピーター ノイマー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Steadymed Ltd
Original Assignee
Steadymed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steadymed Ltd filed Critical Steadymed Ltd
Publication of JP2020519593A publication Critical patent/JP2020519593A/ja
Publication of JP2020519593A5 publication Critical patent/JP2020519593A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2019561320A 2017-05-11 2018-05-10 溶解度を増強させた薬物含有製剤 Pending JP2020519593A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762504546P 2017-05-11 2017-05-11
US62/504,546 2017-05-11
PCT/IL2018/050511 WO2018207188A1 (en) 2017-05-11 2018-05-10 Enhanced solubility drug-containing formulations

Publications (2)

Publication Number Publication Date
JP2020519593A true JP2020519593A (ja) 2020-07-02
JP2020519593A5 JP2020519593A5 (https=) 2021-07-26

Family

ID=62599659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019561320A Pending JP2020519593A (ja) 2017-05-11 2018-05-10 溶解度を増強させた薬物含有製剤

Country Status (9)

Country Link
US (1) US11672863B2 (https=)
EP (1) EP3621591A1 (https=)
JP (1) JP2020519593A (https=)
KR (1) KR20200018438A (https=)
CN (1) CN110869000A (https=)
AU (1) AU2018265624A1 (https=)
CA (1) CA3063322A1 (https=)
IL (1) IL271673A (https=)
WO (1) WO2018207188A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3621591A1 (en) 2017-05-11 2020-03-18 Steadymed Ltd. Enhanced solubility drug-containing formulations
AU2020323594B2 (en) * 2019-08-01 2022-02-03 Incarda Therapeutics, Inc. Antiarrhythmic formulation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08503695A (ja) * 1992-09-10 1996-04-23 チルドレンズ メディカル センター コーポレイション 局所麻酔剤の持続性送達のための生分解性ポリマーマトリックス
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
JP2001516714A (ja) * 1997-09-18 2001-10-02 スカイファーマ インコーポレーテッド 持続放出性リポソーム麻酔組成物
JP2008545694A (ja) * 2005-05-25 2008-12-18 ナヴィンタ リミテッド ライアビリティ カンパニー 等張性水性ロピバカイン注射液の製法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910260A (en) 1972-03-01 1975-10-07 Survival Technology Method and apparatus of treating heart attack patients prior to the establishment of qualified direct contact personal care
US4004577A (en) 1972-12-04 1977-01-25 Survival Technology, Inc. Method of treating heart attack patients prior to the establishment of qualified direct contact personal care
US3941130A (en) 1975-03-18 1976-03-02 Tibbs Robert C Sequential trigger release for injection device
US4261358A (en) 1979-10-01 1981-04-14 Walter Vargas Automatic syringe plunger
US4795433A (en) 1985-05-20 1989-01-03 Survival Technology, Inc. Automatic injector for emergency treatment
US4689042A (en) 1985-05-20 1987-08-25 Survival Technology, Inc. Automatic medicament ingredient mixing and injecting apparatus
US4902692A (en) * 1988-03-18 1990-02-20 Iolab Corporation Method and composition for ophthalmic anesthesia using rodocaine
US5085642A (en) 1989-07-17 1992-02-04 Survival Technology, Inc. Conveniently carried frequent use autoinjector
US5102393A (en) 1989-07-17 1992-04-07 Survival Technology, Inc. Autoinjector converted from intramuscular to subcutaneous mode of injection
US5092843A (en) 1990-04-12 1992-03-03 Survival Technology, Inc. Dispersion multichamber auto-injector
US5267963A (en) 1992-08-21 1993-12-07 Nicholas Bachynsky Medication injection device
US5922340A (en) 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US6149626A (en) 1997-10-03 2000-11-21 Bachynsky; Nicholas Automatic injecting syringe apparatus
SE9803662D0 (sv) 1998-10-26 1998-10-26 Pharmacia & Upjohn Ab Autoinjector
JP4775807B2 (ja) * 2004-12-02 2011-09-21 株式会社 メドレックス 局所麻酔薬物含有ゼリー剤
MX2008016335A (es) 2006-06-30 2009-01-21 Abbott Biotech Ltd Dispositivo automatico de inyeccion.
CN101744760A (zh) * 2008-12-18 2010-06-23 梁颖 用于难溶性或易分解性药物的缓释体
CN102106806B (zh) * 2009-12-29 2013-04-17 上海中西制药有限公司 一种固体制剂的制备方法及所得固体制剂
CA2910865C (en) * 2014-07-15 2016-11-29 Isa Odidi Compositions and methods for reducing overdose
EP3375456B1 (en) * 2015-11-12 2023-05-03 Terumo Kabushiki Kaisha Sustained-release topically administered agent
EP3621591A1 (en) 2017-05-11 2020-03-18 Steadymed Ltd. Enhanced solubility drug-containing formulations

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08503695A (ja) * 1992-09-10 1996-04-23 チルドレンズ メディカル センター コーポレイション 局所麻酔剤の持続性送達のための生分解性ポリマーマトリックス
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
JP2001516714A (ja) * 1997-09-18 2001-10-02 スカイファーマ インコーポレーテッド 持続放出性リポソーム麻酔組成物
JP2008545694A (ja) * 2005-05-25 2008-12-18 ナヴィンタ リミテッド ライアビリティ カンパニー 等張性水性ロピバカイン注射液の製法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEM. PHARM. BULL., vol. 26, no. 3, JPN6022022244, 1978, pages 936 - 941, ISSN: 0004790888 *
JOURNAL OF CONTROLLED RELEASE, vol. 23, JPN6022022242, 1993, pages 261 - 270, ISSN: 0004790887 *
日本臨床麻酔学会誌, vol. 13, no. 3, JPN6022055168, 1993, pages 258 - 263, ISSN: 0004960709 *

Also Published As

Publication number Publication date
KR20200018438A (ko) 2020-02-19
US11672863B2 (en) 2023-06-13
CN110869000A (zh) 2020-03-06
US20200054754A1 (en) 2020-02-20
WO2018207188A1 (en) 2018-11-15
IL271673A (en) 2020-02-27
EP3621591A1 (en) 2020-03-18
CA3063322A1 (en) 2018-11-15
AU2018265624A1 (en) 2019-12-05

Similar Documents

Publication Publication Date Title
AU2018264078B2 (en) Novel analgesic compositions
WO2025054397A1 (en) Parenteral formulations for n,n-dimethyltryptamine (dmt) and dmt analogs, methods of making, and methods of use thereof
CN115068414A (zh) 供注射用罗哌卡因长效溶液制剂及其制备方法
US11672863B2 (en) Enhanced solubility drug-containing formulations
US20220387386A1 (en) Pharmaceutical composition for treating migraine
JP2023501086A (ja) 新規小児用配合剤
EP2874602B1 (en) Injectable supersaturated acetaminophen solution for spinal administration
WO2017023361A1 (en) Pharmaceutical composition comprising sumatripan for treating migraine
TWI516282B (zh) A taxane-containing drug solution containing a pH adjusting agent and a preparation method thereof
OA17190A (en) Injectable supersaturated acetaminophen solution for spinal administration.
WO2011047636A1 (zh) 一种含有助溶剂的紫杉烷类药物溶液及其制备方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210506

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210506

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220606

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220902

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221104

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230111